SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (NASDAQ:CYTX) will webcast their corporate presentation at the Biotech Showcase™ at 11:00 AM PT (2:00 PM ET) on Monday, January 13. The presentation will be held in the Mission II room of the Parc 55 Wyndham Hotel in San Francisco.

The presentation webcast may be accessed on the "Webcasts" page of the Investor Relations section of the Company's website. The webcast can be accessed live and will be available for replay approximately one hour after the presentation on the Company's website.

In addition, Cytori's CEO Chris Calhoun will be participating in a panel at the Alliance for Regenerative Medicine's (ARM) State of the Industry Briefing. The panel discussion will be filmed and will be made available at a later date on the ARM website. The details are as follows:

Biotech Showcase™ 2014: ARM's Regenerative Medicine State of the Industry Briefing

About Cytori

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution System product family. www.cytori.com

Source: Cytori Therapeutics, Inc.

distributed by